Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HESTEKLINIK HERNING ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   3.2% 3.4% 4.7% 2.6% 6.0% 4.6% 14.6% 14.6%   Credit score (0-100)   58 56 47 63 39 44 14 14   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   548 747 657 844 740 748 0.0 0.0   EBITDA   334 281 239 430 8.2 150 0.0 0.0   EBIT   184 112 24.4 191 -158 8.3 0.0 0.0   Pre-tax profit (PTP)   178.4 115.4 26.2 187.4 -155.8 26.8 0.0 0.0   Net earnings   138.4 90.0 18.8 145.9 -122.4 20.6 0.0 0.0   Pre-tax profit without non-rec. items   178 115 26.2 187 -156 26.8 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   360 327 543 343 249 156 0.0 0.0   Shareholders equity total   449 539 558 704 581 602 477 477   Interest-bearing liabilities   73.7 86.4 51.1 38.4 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,085 965 988 1,257 1,239 1,254 477 477   Net Debt   -456 -204 -18.2 -474 -404 -445 -477 -477     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   548 747 657 844 740 748 0.0 0.0   Gross profit growth   0.0% 36.4% -12.1% 28.4% -12.3% 1.0% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,085 965 988 1,257 1,239 1,254 477 477   Balance sheet change%   0.0% -11.1% 2.3% 27.3% -1.5% 1.2% -62.0% 0.0%   Added value   184.4 111.9 24.4 190.7 -158.0 8.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   277 -222 -19 -459 -266 -236 -156 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   33.6% 15.0% 3.7% 22.6% -21.4% 1.1% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   17.6% 12.2% 3.7% 17.0% -11.5% 2.5% 0.0% 0.0%   ROI %   35.1% 21.2% 5.7% 27.9% -21.3% 5.2% 0.0% 0.0%   ROE %   30.8% 18.2% 3.4% 23.1% -19.1% 3.5% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   41.4% 55.8% 56.5% 56.6% 48.2% 48.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -136.3% -72.7% -7.6% -110.3% -4,907.9% -296.2% 0.0% 0.0%   Gearing %   16.4% 16.0% 9.2% 5.5% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   34.5% 12.2% 14.1% 8.4% 63.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   1.1 1.4 0.8 1.5 1.5 1.5 0.0 0.0   Current Ratio   1.1 1.4 1.0 1.7 1.5 1.7 0.0 0.0   Cash and cash equivalent   529.5 290.4 69.3 512.5 404.0 445.3 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   43.7 178.9 -1.7 364.6 345.1 459.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   184 112 24 191 -158 8 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   334 281 239 430 8 150 0 0   EBIT / employee   184 112 24 191 -158 8 0 0   Net earnings / employee   138 90 19 146 -122 21 0 0